Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CIRCUIT: COVID-19 Booster Timing in Immunosuppressed Patients
NCT05415267Phase 3Recruiting
- Sponsor
- The Kirby Institute
- Start
- Jul 2023
- Primary completion
- Dec 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in coronavirus disease 2019 (COVID-19), sponsored by The Kirby Institute. Started Jul 2023; status: recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05415267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05415267.